Researchers at the Commonwealth Scientific and Research Organisation have developed a cloud-based tool, to help tackle big data challenges.
Australia Launches Cloud-Based Tool to Tackle Big Data Challenges
Australia Launches Cloud-Based Tool to Tackle Big Data ChallengesResearchers at the Commonwealth Scientific and Research Organisation have developed a cloud-based tool, to help tackle big data challenges.
Hyperlens Crystal Capable of Viewing Living Cells in Unprecedented Detail
Hyperlens Crystal Capable of Viewing Living Cells in Unprecedented DetailA new hyperlens crystal is capable of resolving details as small as a virus on the surface of living cells.
Breakthrough Discovered in Huntington's Disease
Breakthrough Discovered in Huntington's DiseaseIt has been reported that the causer of the neurodegenerative disease Huntington's has been corrected for the first ever time.
Trudy Mackay to Help Accelerate Clemson Human Genetics Program
Trudy Mackay to Help Accelerate Clemson Human Genetics ProgramTrudy Mackay, renowned "genomic scientist" will gather a team of researchers to advance the understanding of genetic disorders.
Genetics Student Included in Her Campus’ 22 Under 22 Most Inspiring Women
Genetics Student Included in Her Campus’ 22 Under 22 Most Inspiring WomenA 4th year honours student from Alberta who specialises in micro-genetics is being included in Her Campus’ 22 Under 22 list of Most Inspiring Women
It has been reported that the causer of the neurodegenerative disease Huntington’s has been corrected for the first ever time.
Trudy Mackay, renowned “genomic scientist” will gather a team of researchers to advance the understanding of genetic disorders.
A 4th year honours student from Alberta who specialises in micro-genetics is being included in Her Campus’ 22 Under 22 list of Most Inspiring Women
GMI announces new cross-border research collaboration that aims to identify genetic markers, to help diagnose and treat Multiple Sclerosis (MS).
Chinese chemical manufacturing firm Boai NKY Pharmaceuticals plans to purchase BioVision Inc., a drug screening specialist headquartered in San Francisco.
Webinars & Media
A discussion of the technology that is in use today that allows Metabolon to carry out n of 1 studies that enable precision medicine, as well as future technology. Available on-demand.
Looking at applications for the MinION in new molecular approaches for the taxonomy characterization of microbial communities aiming resolution at species and strain level. Available on-demand.
Overcoming challenges of transferring large data to and from the Cloud, while achieving maximum data transfer efficiency, reliability, and security. Available on-demand.
The Short Read
“Ensuring All Stakeholders Understand the Value of Genomics Can Be a Challenge” – Catalina Lopez-Correa
We’ve caught up with GenomeBC’s CSO, Dr. Catalina Lopez-Correa ahead of Festival of Genomics in London, January 2018.
“We Need to be Able to Handle Large Scale Datasets to Prepare for This ‘Big Data’ Era” – Mark Gerstein
Mark Gerstein, PhD, gives us some inside information on applying computational approaches to problems in molecular biology.
We’ve caught up with Luca Magnani ahead of his talk: ‘Diving into the Dark Matter of the Cancer Genome’ at the Festival of Genomics.
Magazines and Educational Guides
In this issue of the magazine we tackle infectious disease, whilst taking a look at what AMP 2017 has on offer this year in Salt Lake City, Utah.
In this issue of the magazine we head to Orlando, Florida, for the largest genetics meeting in the world: welcome to ASHG 2017.
This free guide will introduce you to some of the most important features for genomicists in the cloud.
Just as sequencing has been getting faster, so too has library preparation. The process can be broadly broken up into 5-6 main stages, depending on method.
Technology has come a long way in the last four decades. Dr. Tonellato has been able to watch how it has changed computational genomics for the better.
Does genomics have the power to revolutionise infectious disease control? We have brought together a panel of experts to answer just that.
We’ve caught up with Haim Neerman, CEO of Variantyx, to find out why the clinic is making the move to whole genome sequencing.
With the Festival of Genomics London just around the corner, we thought it was the right time to turn our attention to the key themes being presented.
The Mayo Clinic’s David Smith discusses how Hollywood under-utilize, or so horribly mangle, good science fiction material.
Around the Web
A new hyperlens crystal is capable of resolving details as small as a virus on the surface of living cells.
Researchers from the University of Michigan have identified a vicious cycle of toxic protein production set in motion by cell stress that contributes to ALS
DNA sequences between mitochondria within a single cell are vastly different, researchers have found.
Warming up for the weekend, we have a review of gene therapy, the lab of the future, and schools paving the way for big data analytics.
The most studied genes of all time; iPhone ultrasounds; migration of top life science talent; and still no science advisor at the White House…
Artifical embryos, databases offering clues on who likes beer, self-destruct switches in mosquitos and infectious disease…